The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Postmenopausal estrogen replacement therapy and risk of AD: A population-based study
Abstract
OBJECTIVE: To study the association between estrogen replacement therapy in postmenopausal women and AD using a case-control design. BACKGROUND: Studies of the effect of estrogen therapy on the risk of AD have been limited and have yielded conflicting results. METHODS: Case patients were all postmenopausal women who developed AD in the quinquennium 1980 through 1984 in Rochester, MN (n = 222). One control subject from the same population and free of dementia was matched to each case patient by age (+/-3 years) and length of enrollment in the records-linkage system (n = 222). Estrogen exposure was defined as any form of estrogen (oral, parenteral, topical, suppository) used for at least 6 months after the onset of menopause and before the onset of AD (or corresponding year in the matched control subject). Information on dose and duration of use was abstracted. Consistent with the matched design, analyses entailed conditional logistic regression. RESULTS: AD patients and control subjects had identical age at menarche (median: 13.0 versus 13.0 years) and age at menopause (median: 50.0 versus 50.0 years). The frequency of estrogen use was higher among control subjects than AD patients (10% versus 5%; odds ratio = 0.42; 95% confidence interval 0.18 to 0.96; p = 0.04). There was a significant trend of decreasing odds ratios with increasing duration of use. The inverse association between estrogen therapy and AD remained significant after adjustment for education and age at menopause. CONCLUSION: These results from a population-based study suggest that estrogen replacement therapy is associated with a reduced risk of AD in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
. Cerebral blood flow in dementia.
Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186
Sackett, D. L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90012-2 · Cited by 2,075
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Estrogen Deficiency and Risk of Alzheimer's Disease in Women
Paganini-Hill, A., & Henderson, V. W. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117244 · Cited by 853
The Patient Record in Epidemiology
Kurland, L. T., & Molgaard, C. A. (1981) · Scientific American · doi:10.1038/scientificamerican1081-54 · Cited by 777
Effects of estrogen on memory function in surgically menopausal women
Phillips, S. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90007-t · Cited by 741
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Alzheimer's disease: A study of epidemiological aspects
Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984) · Annals of Neurology · doi:10.1002/ana.410150406 · Cited by 525
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Paganini‐Hill, A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.19.2213 · Cited by 524
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Estrogen improves psychological function in asymptomatic postmenopausal women.
Ditkoff, E. C., Crary, W. G., Cristo, M., & Lobo, R. A. (1991) · PubMed · Cited by 408
FLICKER, C., DEAN, R., WATKINS, D., FISHER, S., & BARTUS, R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(83)80023-9 · Cited by 370
Amaducci, L. A., Fratiglioni, L., Rocca, W. A., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.922 · Cited by 365
Self-citationBrenner, D. E., Kukull, W. A., Stergachis, A., van Belle, G., Bowen, J. D., McCormick, W. C., Ten, L., & Larson, E. B. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117245 · Cited by 302
Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
Schneider, L. S., Farlow, M. R., Henderson, V. W., & Pogoda, J. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1580 · Cited by 250
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
92016229 Estrogen improves psychological function in asymptomatic postmenopausal women
Ditkoff, E. C., Crary, W. G., Cristo, M., & Lobo, R. A. (1992) · Maturitas · doi:10.1016/0378-5122(92)90090-q · Cited by 212
Prevalence of medically diagnosed dementia in a defined United States population
Kokmen, E., Beard, C. M., Offord, K. P., & Kurland, L. T. (1989) · Neurology · doi:10.1212/wnl.39.6.773 · Cited by 137
Self-citationLuine, V. N., Park, D., Joh, T. H., Reis, D. J., & McEwen, B. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90332-7 · Cited by 125
Estrogen and Cognitive Functioning in Surgically Menopausal Womena
Sherwin, B. B., & Phillips, S. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30379.x · Cited by 118
Is the incidence of dementing illness changing?
Kokmen, E., Beard, C. M., O’Brien, P. C., OFFORD, K. P., & Kurland, L. T. (1993) · Neurology · doi:10.1212/wnl.43.10.1887 · Cited by 99
Self-citationThe prevalence of dementia is changing over time in Rochester, Minnesota
Beard, C. M., Kokmen, E., O’Brien, P. C., & Kurland, L. T. (1995) · Neurology · doi:10.1212/wnl.45.1.75 · Cited by 90
Self-citationEpidemiology of Dementia in Rochester, Minnesota
Kokmen, E., Beard, C. M., O’Brien, P. C., & Kurland, L. T. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.275 · Cited by 80
Self-citationSensitivity and Specificity of Death Certificate Diagnoses for Dementing Illnesses, 1988–1990
Macera, C. A., Sun, R. K. P., Yeager, K. K., & Brandes, D. A. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb02015.x · Cited by 63
Cited by
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citationShumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Self-citationPostmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990
Metadata
- Authors
- Waring, S. C., Rocca, W. A., Petersen, R. C., O’Brien, P. C., Tangalos, E. G., & Kokmen, E.
- Venue
- Neurology
- Published
- 1999-03
- Volume
- 52
- Issue
- 5
- Pages
- 965-965
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2047693500
- Cited by
- 293
- References
- 27
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.